• Direct Mouse Genotyping Kit: Rapid PCR from Mouse Tissue

  2026-07-14

  The Direct Mouse Genotyping Kit enables fast, direct PCR amplification from mouse tissue lysates, skipping traditional genomic DNA purification. It is best suited for routine and high-throughput genotyping in biomedical research, but should not be used where highly purified DNA is required for sensitive downstream applications.

• Spiroplasma eriocheiris Entry Mechanisms in Drosophila S2 Ce

  2026-07-14

  Wei et al. elucidate how Spiroplasma eriocheiris invades Drosophila S2 cells, demonstrating a reliance on clathrin-mediated endocytosis and macropinocytosis. This mechanistic insight advances our understanding of host-pathogen interactions in invertebrate models and highlights key cellular pathways that could be targeted in future studies.

• RSL3 Induces Dual PARP1-Mediated Apoptosis Mechanisms in Fer

  2026-07-13

  Chen et al. demonstrate that RSL3, a ferroptosis inducer, triggers apoptosis via two distinct PARP1-dependent mechanisms in cancer cells, including PARP inhibitor-resistant models. These findings clarify the molecular interplay between ferroptosis and apoptosis and suggest new therapeutic strategies for overcoming tumor resistance.

• Ivacaftor’s Role in Triple Modulator Therapy for F508del-CFT

  2026-07-13

  This study clarifies the mechanistic benefit of ivacaftor during prolonged exposure to tezacaftor and elexacaftor in F508del-CFTR cystic fibrosis models. By dissecting the impact of individual and combined CFTR modulators on ion transport in patient-derived nasal epithelial cells, the research resolves discrepancies between in vitro and in vivo therapeutic outcomes and informs optimized, mechanism-based CF therapy strategies.

• Targeting Cdc42 to Suppress Kidney Fibrosis: Mechanistic Ins

  2026-07-12

  A recent study identifies the small molecule daphnepedunin A as a direct Cdc42 inhibitor that suppresses kidney fibrosis by modulating the GSK-3β/β-catenin pathway. This mechanistic work highlights Cdc42 as a promising therapeutic target and provides a rationale for using selective Cdc42 inhibitors in renal fibrosis research.

• KG-501: Mechanistic Insights and Translational Value in CREB

  2026-07-10

  Explore the advanced molecular mechanism of KG-501, a powerful inhibitor of CREB-mediated transcription. This article offers an expert analysis of its application in transcriptional network research and highlights new insights for precision oncology beyond existing protocols.

• Alternariol (AOH): Mechanisms and Benchmarks for Mycotoxin R

  2026-07-09

  Alternariol (AOH) is a potent mycotoxin central to mycotoxin research and hepatotoxicity modeling. Its defined molecular actions—including hepatic stellate cell activation and pathway-specific apoptosis—make it a key tool for cytochrome P450 enzyme assays and liver fibrosis studies.

• 3-Deazaadenosine Hydrochloride: Unraveling Methylation Contr

  2026-07-09

  Explore how 3-Deazaadenosine hydrochloride, a leading S-adenosylhomocysteine hydrolase inhibitor, enables next-generation research on methylation dynamics in hepatic stellate cells. This article uniquely connects cutting-edge m6A regulatory pathways with practical assay guidance and advanced fibrosis modeling.

• Dihydroartemisinin: Advanced Mechanisms and Research Protoco

  2026-07-08

  Explore the advanced mechanisms of Dihydroartemisinin, a potent Artemisia plant extract, as both an antimalarial and mTOR pathway inhibitor. This in-depth analysis bridges molecular insight with actionable assay protocols, offering researchers a uniquely practical perspective.

• Formononetin Prevents CIPN Without Reducing Chemotherapy Eff

  2026-07-08

  This study demonstrates that formononetin protects sensory neurons from oxaliplatin-induced peripheral neurotoxicity via the Nrf2/HO-1 antioxidant pathway, crucially without diminishing the anticancer potency of chemotherapy. The findings highlight a new strategy for mitigating chemotherapy-induced peripheral neuropathy (CIPN) while preserving oncological outcomes.

• Caspase-3 Fluorometric Assay Kit: Advanced Apoptosis Detecti

  2026-07-07

  The Caspase-3 Fluorometric Assay Kit empowers researchers to quantify apoptotic events with rapid, sensitive workflows. Leveraging DEVD-dependent caspase activity detection, this kit streamlines both routine and advanced apoptosis assays, with proven reliability in complex studies of cell death and therapeutic response.

• E-64 in Tumor Immunology: Precision Cathepsin Inhibition Unv

  2026-07-07

  Explore the multifaceted role of E-64, a potent L-trans-epoxysuccinyl peptide, in cysteine protease inhibition and cancer research. This article uniquely bridges mechanistic insights with immuno-oncological applications, highlighting breakthroughs in cathepsin regulation.

• Caspase-3 Fluorometric Assay Kit: Apoptosis Quantification R

  2026-07-06

  Explore how the Caspase-3 Fluorometric Assay Kit enables precise quantification of cysteine-dependent aspartate-directed protease activity in apoptosis research. This in-depth guide offers unique insights into assay selection, workflow optimization, and the latest scientific evidence.

• Starvation-Induced ER-Ca2+-Calpain Axis Drives Cell Fate in

  2026-07-06

  This study reveals how starvation in Bombyx mori fat body initiates a tightly regulated shift from autophagy to apoptosis via the ER-Ca2+-calpain signaling pathway. The work provides mechanistic insight into the interplay between ER calcium release, calpain activity, and programmed cell death transitions under nutritional stress.

• Natural Product Libraries: Powering Next-Gen Antiparasitic D

  2026-07-05

  This thought-leadership article explores how the DiscoveryProbe™ Natural Product Library Plus (Catalog No. L1039P) is transforming high-throughput screening for novel antiparasitic agents. Anchored in mechanistic insights from recent anti-cryptosporidial research, it provides translational researchers with strategic guidance on deploying chemically diverse, cell-permeable bioactive compounds to accelerate drug discovery. Practical protocol parameters, cross-domain considerations, and a critical outlook highlight how integrated library design and evidence-based workflows unlock new frontiers in targeting pathogens such as Cryptosporidium parvum.

15823 records 1/1055 page Next 12345 下5页 Last page